Olfactory Bulb Integrity in Frontotemporal Dementia and Alzheimer's Disease

被引:8
|
作者
Carnemolla, Sarah E. [1 ,2 ]
Kumfor, Fiona [1 ,2 ]
Liang, Cheng Tao [1 ,2 ]
Foxe, David [1 ,2 ]
Ahmed, Rebekah M. [2 ,3 ,4 ]
Piguet, Olivier [1 ,2 ]
机构
[1] Univ Sydney, Sch Psychol, Sydney, NSW, Australia
[2] Univ Sydney, Brain & Mind Ctr, 94 Mallett St, Sydney, NSW 2006, Australia
[3] Royal Prince Alfred Hosp, Dept Clin Neurosci, Memory & Cognit Clin, Sydney, NSW, Australia
[4] Univ Sydney, Cent Sydney Med Sch, Sydney, NSW, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
Alzheimer's disease; frontotemporal dementia; magnetic resonance imaging; neurodegeneration; olfaction; olfactory bulb; MILD COGNITIVE IMPAIRMENT; PROGRESSIVE NONFLUENT APHASIA; ANXIETY STRESS SCALES; ODOR IDENTIFICATION; BEHAVIORAL VARIANT; SEMANTIC DEMENTIA; MITRAL CELLS; VOLUME; SMELL; PREVALENCE;
D O I
10.3233/JAD-220080
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Olfactory dysfunction is highly prevalent in dementia syndromes, including Alzheimer's disease (AD) and frontotemporal dementia (FTD). The structural integrity of the olfactory bulb (OB) is thought to play a critical role in odor detection and identification, but no MRI study has measured OB volume in FTD, or measured OB volume longitudinally in AD. Objective: To measure OB volume in FTD and AD patients longitudinally using MRI. Methods: This study measured OB volumes using MRI in patients diagnosed with behavioral-variant FTD (n = 55), semantic dementia (n = 34), progressive non-fluent aphasia (n = 30), AD (n = 50), and healthy age-matched controls (n = 55) at their first visit to a dementia research clinic ('baseline'). Imaging data in patients 12-months later were analyzed where available (n = 84) for longitudinal assessment. Volumes of subcortical and cortical olfactory regions ('olfactory network') were obtained via surface-based morphometry. Results: Results revealed that in AD and FTD at baseline, OB volumes were similar to controls, whereas volumes of olfactory network regions were significantly reduced in all patient groups except in progressive non-fluent aphasia. Longitudinal data revealed that OB volume became significantly reduced (10-25% volume reduction) in all dementia groups with disease progression. Conclusion: Olfactory dysfunction is common in patients diagnosed with AD or FTD, but our results indicate that there is no detectable volume loss to the OBs upon first presentation to the clinic. Our findings indicate that the OBs become detectably atrophied later in the disease process. OB atrophy indicates the potential usefulness for OBs to be targeted in interventions to improve olfactory function.
引用
收藏
页码:51 / 66
页数:16
相关论文
共 50 条
  • [41] Metamemory accuracy in Alzheimer's disease and frontotemporal lobe dementia
    Souchay, C
    Isingrini, M
    Pillon, B
    Gil, R
    NEUROCASE, 2003, 9 (06) : 482 - 492
  • [42] Cerebellum in Alzheimer's disease and frontotemporal dementia: not a silent bystander
    Schmahmann, Jeremy D.
    BRAIN, 2016, 139 : 1314 - 1318
  • [43] Medication Use Differs in Alzheimer's Disease and Frontotemporal Dementia
    Hu, Bei
    Tartaglia, Maria Carmela
    Mehta, Kala
    Miller, Bruce
    Boxer, Adam
    NEUROLOGY, 2011, 76 (09) : A78 - A78
  • [44] Everyday action in frontotemporal dementia versus Alzheimer's disease
    Sestito, N
    Giovannetti, T
    Libon, DJ
    CLINICAL NEUROPSYCHOLOGIST, 2006, 20 (02) : 204 - 204
  • [45] Apathy in frontotemporal dementia and Alzheimer's disease: are there distinct profiles?
    Derouesne, Christian
    Lacomblez, Lucette
    Fiori, Nicole
    Gely-Nargeot, Marie-Christine
    Bungener, Catherine
    GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT, 2012, 10 (01): : 106 - 114
  • [46] Distinctive Oculomotor Behaviors in Alzheimer's Disease and Frontotemporal Dementia
    Lage, Carmen
    Lopez-Garcia, Sara
    Bejanin, Alexandre
    Kazimierczak, Martha
    Aracil-Bolanos, Ignacio
    Calvo-Cordoba, Alberto
    Pozueta, Ana
    Garcia-Martinez, Maria
    Fernandez-Rodriguez, Andrea
    Bravo-Gonzalez, Maria
    Jimenez-Bonilla, Julio
    Banzo, Ignacio
    Irure-Ventura, Juan
    Pegueroles, Jordi
    Illan-Gala, Ignacio
    Fortea, Juan
    Rodriguez-Rodriguez, Eloy
    Lleo-Bisa, Alberto
    Garcia-Cena, Cecilia E.
    Sanchez-Juan, Pascual
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 12
  • [47] First symptoms - Frontotemporal dementia versus Alzheimer's disease
    Lindau, M
    Almkvist, O
    Kushi, J
    Boone, K
    Johansson, SE
    Wahlund, LO
    Cummings, JL
    Miller, BL
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2000, 11 (05) : 286 - 293
  • [48] Insight deficits (anosognosia) in frontotemporal dementia and Alzheimer's disease
    Caixeta, L
    Nitrini, R
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S60 - S60
  • [49] Apolipoprotein D Upregulation in Alzheimer’s Disease but Not Frontotemporal Dementia
    Surabhi Bhatia
    Woojin Scott Kim
    Claire E. Shepherd
    Glenda M. Halliday
    Journal of Molecular Neuroscience, 2019, 67 : 125 - 132
  • [50] Memory encoding and retrieval in frontotemporal dementia and Alzheimer's disease
    Glosser, G
    Gallo, JL
    Clark, CM
    Grossman, M
    NEUROPSYCHOLOGY, 2002, 16 (02) : 190 - 196